Inamed to Report Weak 4th-Quarter Earnings

Inamed Corp., a maker of breast implants and other plastic-surgery products, said fourth-quarter sales and profit fell below its previous estimates and President and Co-Chief Executive Ilan Reich resigned. Santa Barbara-based Inamed expects to report fourth-quarter earnings of 32 cents to 34 cents on sales of $58 million. The company had forecast profit of 45 cents to 55 cents on sales of $61 million to $67 million. Slower sales of breast implants and products that reduce facial wrinkles and enhance lips contributed to the shortfall, the company said. Shares rose 50 cents to close at $21.13 on Nasdaq. Inamed also lowered estimates for sales and earnings for the year.